Active ingredientGriseofulvinCat. No. P-G063-001CAS 126-07-8Family · Pharmaceutical analytical standards
Griseofulvin
An antifungal made by the soil mould Penicillium griseofulvum, first described in 1939 in England by Albert Oxford, Harold Raistrick and Paul Simonart. It is taken by mouth against ringworm of the skin, scalp and nails caused by dermatophytes. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It works patiently: it binds to the keratin of the cells about to form skin, hair and nails, so the new tissue grows already resistant to the fungus and gradually replaces the infected tissue.
Go to the active ingredient →Active ingredientGriseofulvinCat. No. P-G063-001CAS 126-07-8
Pharmacopoeial impurityGriseofulvin EP Impurity BCat. No. P-G063-002CAS 3680-32-8
Pharmacopoeial impurityrac-Griseofulvin EP Impurity CCat. No. P-G063-003CAS 7776-77-4
Isotopically labelledGriseofulvin-13C-d3Cat. No. P-G063-004
Isotopically labelledGriseofulvin-d3Cat. No. P-G063-005CAS 1279033-22-5
ImpurityDechloro Dehydro GriseofulvinCat. No. P-G063-006CAS 1427177-15-8
Pharmacopoeial impurityGriseofulvin EP Impurity CCat. No. P-G063-007CAS 3573-90-8
ImpurityEpigriseofulvinCat. No. P-G063-008CAS 469-49-8
Pharmacopoeial impurityGriseofulvin EP Impurity ACat. No. P-G063-009CAS 469-54-5
ImpurityGriseofulvin for LC assay and identificationCat. No. P-G063-010CAS 126-07-8
ImpurityGriseofulvin Impurity 1Cat. No. P-G063-012CAS 20168-88-1No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceGriseofulvin for LC assay and identification CRSEDQM code Y0002046Family GriseofulvinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.